Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid

Sach, Tracey (2018) Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid. British Journal of Dermatology, 178 (2). pp. 320-321. ISSN 0007-0963

Full text not available from this repository. (Request a copy)

Item Type:	Article
Uncontrolled Keywords:	cost-benefit analysis,doxycycline,humans,pemphigoid, bullous,prednisolone,quality-adjusted life years
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	LivePure Connector
Date Deposited:	16 Jul 2020 23:47
Last Modified:	18 Jul 2025 01:31
URI:	https://ueaeprints.uea.ac.uk/id/eprint/76154
DOI:	10.1111/bjd.16226

Actions (login required)

View Item